Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trialResearch in context
Summary: Background: Long-term effects of human mesenchymal stem cell (MSC) treatment on COVID-19 patients have not been fully characterized. The aim of this study was to evaluate the safety and efficacy of a MSC treatment administered to severe COVID-19 patients enrolled in our previous randomized...
Main Authors: | Tian-Tian Li, Bo Zhang, Hui Fang, Ming Shi, Wei-Qi Yao, Yuanyuan Li, Chao Zhang, Jinwen Song, Lei Huang, Zhe Xu, Xin Yuan, Jun-Liang Fu, Cheng Zhen, Yu Zhang, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Tengyun Dong, Ruidan Bai, Lulu Zhao, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei-Fen Xie, Yonggang Li, Lei Shi, Fu-Sheng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396423001652 |
Similar Items
-
Clinical efficacy of transforaminal endoscopic discectomy in the treatment of recurrent lumbar disc herniation: a single-center retrospective analysis
by: Gang Xu, et al.
Published: (2023-01-01) -
Analyzing breast cancer invasive disease event classification through explainable artificial intelligence
by: Raffaella Massafra, et al.
Published: (2023-02-01) -
Mental health service requirements after hospitalization due to COVID-19: a 1- year follow-up study
by: J. Andreo Jover, et al.
Published: (2022-06-01) -
Association of the Weight-Adjusted-Waist Index With Risk of All-Cause Mortality: A 10-Year Follow-Up Study
by: Shuang Cai, et al.
Published: (2022-05-01) -
Time trends in the burden of low back pain and its associated risk factors in China from 1990 to 2019
by: Jiahao Zhang, et al.
Published: (2024-03-01)